Price quotes for Zetia from multiple providers

Merck & Co. has received an additional six months of patent protection in the United States for its cholesterol-lowering drug Zocor. The patent, which was due to expire after December 23, 2005, now extends to June 23, 2006. Merck, which achieves annual sales of more than $6 billion with Zocor, is seeking to enhance the Zocor franchise through a partnership with Schering-Plough Corp.

…